Novo Nordisk A/S Class B Stock 12‑Month Price Target Cut to DKK 318.84, Implies 4% Upside

• According to estimates from 30 analysts, Novo Nordisk A/S Class B stock's average price target has fallen from DKK 324.87 to DKK 318.84, with forecasts ranging from DKK 200 to DKK 453 per share
• Based on the Aug. 4 closing price, the updated target implies approximately 4% potential upside
• Consensus rating remains at “Buy” across 38 covering analysts, with 14 Buys, 21 Holds and 3 Sells

Explore more price target data and ratings for Novo Nordisk A/S Class B on the , and track all previous and future analyst recommendations for Novo Nordisk A/S Class B in the dedicated .

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.